For comparison, Pfizer reported yesterday that Abrysvo made full-year sales of $890 million, which - while respectable - were well below its competitor. However, it brought in $515 million in the ...

It's notable, however, that Arexvy's main rival in the RSV vaccine space – Pfizer's Abrysvo – held up much better in the third quarter, with sales slipping only around 5% to $356 million.

We are so very excited that there are now two new ways to protect our smallest family members from RSV: Moms can get the Abrysvo vaccine during pregnancy. This works to protect the baby by having ...

Across China’s west, the Communist Party is placing children in boarding schools to assimilate a generation of Tibetans into the national mainstream and mold them into loyal citizens. By Chris ...

Jan. 8, 2025 — An academic has used drone mapping to investigate a 3000-year-old 'mega fortress' in the Caucasus mountains, revealing details that re-shape ... How Deep Sleep Clears a Mouse's ...

After Donald Trump suggested he might take over Greenland by force, the consensus among the island’s population appears to be bewilderment and anxiety. By Jeffrey Gettleman and Maya Tekeli The ...

A state of emergency has been declared in Russia's western city of Engels, according to the region's governor. It comes after Ukraine said it was behind a drone strike on a Russian oil base in the ...